Literature DB >> 20113840

Molecular cytogenetic studies characterize a near-triploid complex karyotype in a child with acute lymphoblastic leukemia.

Hasmik Mkrtchyan1, Daniela Ribeiro Garcia Ney, Eliane Soares de Ventura, Thomas Liehr, Gabriel Rafael Felix, Terezinha de Jesus Marques-Salles, Eliana Abdelhay, Maria Luiza Macedo Silva.   

Abstract

High hyperdiploidy with modal chromosome numbers between 50 and 65 is common in childhood acute lymphoblastic leukemia (ALL), occurring in 25-30% of the cases. This chromosomal constitution is associated with a very good prognosis. By contrast, near triploidy and tetraploidy are found in <1% of childhood ALL. Given the sparseness of this group, the associated chromosomal abnormalities and their prognostic implications have not yet been studied in detail. Here, we describe clinical and molecular cytogenetic findings in a child with ALL who had a near-triploid complex karyotype, with loss and gain of chromosomes, including extra copies of the same derivative chromosomes. These findings suggest a random nondisjunction mechanism for near triploidy in the present case. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20113840     DOI: 10.1016/j.cancergencyto.2009.09.019

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  An unusual T-cell childhood acute lymphoblastic leukemia harboring a yet unreported near-tetraploid karyotype.

Authors:  Daniela Rn Garcia; Samarth Bhatt; Marina Manvelyan; Mariana T de Souza; Renata Binato; Thais F Aguiar; Eliana Abdelhay; Maria Luiza M Silva
Journal:  Mol Cytogenet       Date:  2011-09-21       Impact factor: 2.009

2.  Identification of chromosomal abnormalities and genomic features in near-triploidy/tetraploidy-acute leukemia by fluorescence in situ hybridization.

Authors:  Ruqing Yang; Minghua Jiang; Junzhao Zhao; Hui Chen; Jian Gong; Yaying You; Laiyue Song; Zhen Li; Qian Li
Journal:  Cancer Manag Res       Date:  2019-02-15       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.